Psychosocial needs and supportive care needs after subarachnoid hemorrhage: Detection and evaluation

Psychosocial needs and supportive care needs after subarachnoid hemorrhage: Detection and evaluation - PERSUADE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040742

Enrollment

Registered

2026-06-23

Start date

2026-06-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysmal Subarachnoid Hemorrhage

Interventions

Group 1: Guided, qualitative interviews with patients following an aneurysmal subarachnoid hemorrhage Standardized questionnaires Group 2: Guided, qualitative interviews with family members of patient

the discussions in these groups, as well as the qualitative interviews, will be analyzed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have experienced an aneurysmal subarachnoid hemorrhage OR Caregivers of patients with aneurysmal subarachnoid hemorrhage: Regularly provide supportive care—whether nursing, emotional, and/or organizational 2. Age: = 18 years 3. Severity: WFNS grade = III 4. Language: Sufficient proficiency in German 5. Sufficient cognitive function 6. Capacity to give informed consent Treating physician: Experience in treating aSAH patients (neurosurgery, neuroradiology, or anesthesiology)

Exclusion criteria

Exclusion criteria: Additional untreated aneurysms

Design outcomes

Primary

Measure	Time frame
The goal is to determine care needs based on qualitative (and quantitative) data. Qualitative Interviews As part of this study, qualitative interviews will be conducted with patients who have experienced an aneurysmal subarachnoid hemorrhage (aSAB). A total of 12 patients, 8–12 family members, and 4–6 healthcare providers of aSAB patients will be interviewed by a member of the study team using a semi-structured interview guide. The interviews will last approximately 30 to 40 minutes for patients and family members, and approximately 20 minutes for healthcare providers. The qualitative data will be analyzed using Mayring’s methodology, with the qualitative data (interviews and focus groups) being analyzed jointly (convergent) with the quantitative data. Focus Groups Following the qualitative interviews and standardized questionnaires, qualitative focus groups are planned for patients and family members. These are guided and moderated group discussions between patients and family members (5–8 participants per group; family members and patients in separate groups). Like the interviews, these are transcribed and analyzed according to Mayring’s methodology.	—

Measure

Time frame

The goal is to determine care needs based on qualitative (and quantitative) data. Qualitative Interviews As part of this study, qualitative interviews will be conducted with patients who have experienced an aneurysmal subarachnoid hemorrhage (aSAB). A total of 12 patients, 8–12 family members, and 4–6 healthcare providers of aSAB patients will be interviewed by a member of the study team using a semi-structured interview guide. The interviews will last approximately 30 to 40 minutes for patients and family members, and approximately 20 minutes for healthcare providers. The qualitative data will be analyzed using Mayring’s methodology, with the qualitative data (interviews and focus groups) being analyzed jointly (convergent) with the quantitative data. Focus Groups Following the qualitative interviews and standardized questionnaires, qualitative focus groups are planned for patients and family members. These are guided and moderated group discussions between patients and family members (5–8 participants per group; family members and patients in separate groups). Like the interviews, these are transcribed and analyzed according to Mayring’s methodology.

—

Secondary

Measure	Time frame
Standardized Questionnaires To supplement the qualitative data, quantitative questionnaire data is also collected from patients using paper-based forms. This data is collected immediately following the qualitative interview (duration: approximately 20 minutes). The following questionnaires and constructs are assessed: • Sociodemographics: age, relationship status, number of minor children, highest level of education attained • Questions regarding previous mental health/psychiatric diagnoses • Questions regarding current psychopharmacological treatment • Questions regarding significant pre-existing physical conditions • PHQ-ADS (Patient Health Questionnaire Anxiety and Depression Scale): Measures the severity of depressive and anxiety symptoms (Kroenke et al., 2016). • PA-F-KF (Progression Anxiety Questionnaire): Assesses illness-related fear of progression or concerns about worsening/recurrence in key areas of life (including emotions, family, work, and autonomy; Mehnert et al., 2006). • PCL-5-SF (Posttraumatic Stress Disorder Symptom Checklist): Assesses the extent of posttraumatic stress symptoms according to the DSM-5 as a screening tool and measure of severity (Zuromski et al., 2019; Krüger-Goeschalk et al., 2017). • SIS (Six-Item Screener): Serves as a brief cognitive screener to assess possible cognitive impairments (particularly orientation and memory; Krupp et al., 2018). • Questionnaire on the Needs of Stroke Survivors: Assesses unmet or long-term care and support needs in follow-up care (Franzisket et al., 2025). Family members and healthcare providers do not fill out questionnaires.	—

Measure

Time frame

Standardized Questionnaires To supplement the qualitative data, quantitative questionnaire data is also collected from patients using paper-based forms. This data is collected immediately following the qualitative interview (duration: approximately 20 minutes). The following questionnaires and constructs are assessed: • Sociodemographics: age, relationship status, number of minor children, highest level of education attained • Questions regarding previous mental health/psychiatric diagnoses • Questions regarding current psychopharmacological treatment • Questions regarding significant pre-existing physical conditions • PHQ-ADS (Patient Health Questionnaire Anxiety and Depression Scale): Measures the severity of depressive and anxiety symptoms (Kroenke et al., 2016). • PA-F-KF (Progression Anxiety Questionnaire): Assesses illness-related fear of progression or concerns about worsening/recurrence in key areas of life (including emotions, family, work, and autonomy; Mehnert et al., 2006). • PCL-5-SF (Posttraumatic Stress Disorder Symptom Checklist): Assesses the extent of posttraumatic stress symptoms according to the DSM-5 as a screening tool and measure of severity (Zuromski et al., 2019; Krüger-Goeschalk et al., 2017). • SIS (Six-Item Screener): Serves as a brief cognitive screener to assess possible cognitive impairments (particularly orientation and memory; Krupp et al., 2018). • Questionnaire on the Needs of Stroke Survivors: Assesses unmet or long-term care and support needs in follow-up care (Franzisket et al., 2025). Family members and healthcare providers do not fill out questionnaires.

—

Countries

Germany

Contacts

Public ContactSimon Schieferdecker

Klinik für Neurochirurgie, Medizinische Fakultät und Universitätsklinikum (UKD), Heinrich-Heine-Universität (HHU) Düsseldorf

simon.schieferdecker@med.uni-duesseldorf.de02118105343

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026